Clinical characteristics of vivax malaria and analysis of recurred patients

Infection and Chemotherapy

Volumn 45, Issue 1, 2013, Pages 69-75

  Kwak, Yee Gyung ^a   Lee, Hyo Keun ^a   Kim, Min ^a   Um, Tae Hyun ^a   Cho, Chong Rae ^a  

^a Inje University   (South Korea)

Author keywords

Recurrence; Vivax malaria

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHLOROQUINE; CREATININE; GLUCOSE; HEMOGLOBIN; HYDROXYCHLOROQUINE; MALACHLO; PRIMAQUINE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD SMEAR; BODY TEMPERATURE; CHILL; CHRONIC LIVER DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIARRHEA; ENDEMIC DISEASE; FEMALE; FEVER; GLUCOSE BLOOD LEVEL; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; HYPOTENSION; INFECTION RISK; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; MENTAL DISEASE; MYALGIA; NAUSEA; NEOPLASM; PLASMODIUM VIVAX MALARIA; RECURRENT INFECTION; RELAPSE; RESIDENTIAL AREA; RETROSPECTIVE STUDY; SOLDIER; SPLEEN INFARCTION; SPLEEN RUPTURE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UREMIA; VOMITING;

EID: 84879110536     PISSN: 20932340     EISSN: 20926448     Source Type: Journal    
DOI: 10.3947/ic.2013.45.1.69     Document Type: Article

References (19)

1. Yeom JS. Diagnosis and treatment of vivax malaria. Ko rean J Med 2009;77:52-4.
2. Korea Centers for Disease Control and Prevention. Diseases web statistics system. Available at: http://stat.cdc.go.kr/. Accessed on 3 July 2012.
3. Krudsood S, Tangpukdee N, Wilairatana P, Phophak N, Baird JK, Brittenham GM, Looareesuwan S. High-dose primaquine regimens against relapse of Plasmodium vivax malaria. Am J Trop Med Hyg 2008;78:736-40.
4. Baird JK, Hoffman SL. Primaquine therapy for malaria. Clin Infect Dis 2004;39:1336-45.
5. Goller JL, Jolley D, Ringwald P, Biggs BA. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy. Am J Trop Med Hyg 2007;76:203-7.
6. Pukrittayakamee S, Imwong M, Chotivanich K, Singhasivanon P, Day NP, White NJ. A comparison of two shortcourse primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand. Am J Trop Med Hyg 2010;82:542-7.
7. Koo KB, Cho NH, Kim SH, Won YJ, Cho HS. The clinical analysis of 79 cases of indigenous malaia in Myongji hospital during 4 years. J Korean Acad Fam Med 2004;25:403-10.
8. Song HH, O SO, Kim SH, Moon SH, Kim JB, Yoon JW, Koo JR, Hong KS, Lee MG, Kim DJ, Shin DH, Kang SH, Choi MG, Lee KH. Clinical features of Plasmodium vivax malaria. Korean J Med 2002;63:546-51.
9. Ko DH, Kim SS, Choi BS, Seog W, Kim CH, Cho YK, So BJ, Kim CS. Studies on the vivax malaria readmitted in military hospital. Korean J Med 2005;68:611-8.
10. Yeom JS, Park JW. Status of vivax malaria after re-emergence in South Korea. Infect Chemother 2008;40:191-8.
11. Park JW. Status of Plasmodium vivax malaria in the Republic of Korea after reemergence. Hanyang Med Rev 2010;30:176-86.
12. Kho WG. Reemergence of malaria in Korea. J Korean Med Assoc 2007;50:959-66.
13. Centers for Disease Control and Prevention. Treatment of Malaria: Guidelines For Clinicians (United States). Available at: http://www.cdc.gov/malaria/diagnosis_treatment/clinicians2.html. Accessed on 3 July 2012.
14. Yi KJ, Chung MH, Kim HS, Kim CS, Pai SH. A relapsed case of imported tertian malaria after a standard course of hydroxychloroquine and primaquine therapy. Korean J Parasitol 1998;36:143-6.
15. Baird JK. Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother 2004;48:4075-83.
16. Lee KS, Kim TH, Kim ES, Lim HS, Yeom JS, Jun G, Park JW. Short report: chloroquine-resistant Plasmodium vivax in the Republic of Korea. Am J Trop Med Hyg 2009;80:215-7.
17. Schwartz E, Regev-Yochay G, Kurnik D. Short report: a consideration of primaquine dose adjustment for radical cure of Plasmodium vivax malaria. Am J Trop Med Hyg 2000;62:393-5.
18. Takeuchi R, Lawpoolsri S, Imwong M, Kobayashi J, Kaewkungwal J, Pukrittayakamee S, Puangsa-art S, Thanyavanich N, Maneeboonyang W, Day NP, Singhasivanon P. Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border. Malar J 2010;9:308.
19. Duarte EC, Pang LW, Ribeiro LC, Fontes CJ. Association of subtherapeutic dosages of a standard drug regimen with failures in preventing relapses of vivax malaria. Am J Trop Med Hyg 2001;65:471-6.